As one of the largest international biotechnology conferences in Asia, BIOHK2023, the Hong Kong International Biotechnology Forum, commenced on September 13th and concluded successfully on September 16th.

On the conference’s opening day, several government representatives and prominent experts in the field of biology delivered speeches. Notable speakers included Mr. Leung Chun-ying, Vice-Chairman of the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and former Chief Executive of the Special Administrative Region (SAR); Mr. Yu Chang-hai, Chairman of BIOHK2023; and Mr. Bruce Beutler, the recipient of the 2011 Nobel Prize in Biology or Medicine.

This year’s exhibition not only attracted nearly 200 exhibitors from both domestic and international backgrounds, including Hong Kong, but also featured high-end forums and seminars. The event organized 24 symposiums, 4 summit forums, 3 seminars, and 11 round tables. META PHARMACEUTICALS (HK) LIMITED had the honor of being invited to participate in the conference. The company received recognition from professionals for its R&D ideas and achievements in small molecule inhibition of immuno-metabolism, as well as its significant development potential. As a result, it was awarded a place in the top 10 out of the 36 companies’ presentations.

Throughout the four-day exhibition, META Pharmaceuticals’ booth garnered significant attention. Numerous professionals visited to learn and engage in discussions. META eagerly anticipates collaboration and learning opportunities with various outstanding enterprises in the industry.